MedPath

ROPINIROLE

ROPINIROLE

Approved
Approval ID

c2c38b4c-b139-45f2-e053-2995a90a262c

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Nov 22, 2021

Manufacturers
FDA

DIRECT RX

DUNS: 079254320

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

ROPINIROLE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code72189-222
Application NumberANDA204022
Product Classification
M
Marketing Category
C73584
G
Generic Name
ROPINIROLE
Product Specifications
Route of AdministrationORAL
Effective DateNovember 22, 2021
FDA Product Classification

INGREDIENTS (6)

FERRIC OXIDE YELLOWInactive
Code: EX438O2MRT
Classification: IACT
POLYETHYLENE GLYCOL 400Inactive
Code: B697894SGQ
Classification: IACT
ROPINIROLE HYDROCHLORIDEActive
Quantity: 1 mg in 1 1
Code: D7ZD41RZI9
Classification: ACTIM
FD&C BLUE NO. 2Inactive
Code: L06K8R7DQK
Classification: IACT
HYPROMELLOSE 2910 (6 MPA.S)Inactive
Code: 0WZ8WG20P6
Classification: IACT
TITANIUM DIOXIDEInactive
Code: 15FIX9V2JP
Classification: IACT

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

ROPINIROLE - FDA Drug Approval Details